Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Small Cell Lung Carcinoma
×
tremelimumab
×
Clear all
Filters
3
NCT07391670
2026-03-12
IMFINZI-subQ
AstraZeneca
Phase 1
Not yet recruiting
40 enrolled
NCT03703297
2025-11-21
ADRIATIC
AstraZeneca
Phase 3
Active not recruiting
730 enrolled
19 charts
1 FDA
NCT03043872
2025-10-21
CASPIAN
AstraZeneca
Phase 3
Active not recruiting
987 enrolled
42 charts
2 FDA
NCT03509012
2025-01-14
CLOVER
AstraZeneca
Phase 1
Completed
105 enrolled